Kah-Whye Peng is the founder of Vyriad. Vyriad has raised $85M in total funding. Latest round: Series B. Backed by Stine Seed Farms Inc..
Kah-Whye Peng is a co-founder of Vyriad, a clinical-stage biotechnology company based in Rochester, Minnesota. Vyriad develops targeted genetic therapies for cancer and other serious diseases, utilizing engineered viruses, viral vectors, and viral envelope glycoproteins to deliver therapeutic genes. The company was founded by Mayo Clinician-Scientists, Dr. Stephen Russell and Dr. Kah-Whye Peng, to advance their gene and virus therapy research. Vyriad recently closed a $25 million final tranche to its Series B financing, bringing the total Series B round to $85 million.
Full founder directory · Investor directory · Company funding database · Fundraising library